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Abstract
Introduction. Ulcerative colitis is a chronic, inflammatory disease of the mucous membrane of the large intestine manifesting 
itself through diarrhoea with blood, mucous and pus. It progresses with periods of relapses and remissions. The treatment is 
a long-term process which should aim at improving the patient’s clinical condition and quality of life, as well as minimising 
the disease-related anxiety and fears.  
Objective. The aim of the study was recognition of the determinants of the level of anxiety and fears in a group of patients 
with ulcerative colitis.  
Materials and method. The prospective study comprised 102 patients with diagnosed ulcerative colitis. The data were 
collected by means of the following tools: Clinical Disease Activity Index, Rating Form of IBD Patients Concerns (RFIPC), and 
a questionnaire by the authors. Statistical parametric and non-parametric tests were used to analyse the data, depending 
on the type of scale and nature of the variable distribution.  
Results. Most of the patients (64%) were in the active phase of the disease. A high level of fear and anxiety occurred in 73% 
of the patients and concerned the impact of the disease, intimate life, complications and stigmatisation. The highest levels 
of fears and anxiety were observed in the field of complications and the impact of the disease on the patients’ lives.  
Conclusions. The disease activity and high levels of anxiety and fears influenced the psychosocial functioning of the 
patients with ulcerative colitis.
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INTRODUCTION
Ulcerative colitis is diffused, non-specific inflammatory 
process that occurs in the mucosa of the part of the large 
intestine that widens ascending from the anus towards the 
caecum. The majority of patients are white people from 
highly developed countries. The annual incidence is more 
or less constant and amounts to approximately 10 cases per 
100,000 population. The disease is manifested by the presence 
of ecchymosis or ulceration [1]. Due to unknown ethiology, it 
is classified as one of conditions referred to as inflammatory 
bowel disease (IBD). Etiopathogenesis of ulcerative colitis 
is multifactorial and complex [1, 2, 3]. Current knowledge 
indicates a few factors affecting the disease occurrence, for 
instance: genetic predisposition, environmental factors, 
immunological and psychosomatic factors. The nuisance of 
the disease is caused by periods of relapse and accompanying 
symptoms: bloody diarrhoea, fever, pains which significantly 
impair the life and professional activity of the patients [4]. 
Ulcerative colitis is particularly stressful for the patients. 
Numerous fears and anxieties related to the endoscopic 
examination, possible mutilating surgery and the risk of 
colorectal cancer development have an enormous impact on 
the patients’ mental sphere [5].
OBJECTIVE
The recognition of determinants of the level of anxiety and 
fears in patients with ulcerative colitis.
MATERIALS AND METHOD
The sample group consisted of 102 patients with confirmed 
clinical diagnosis of ulcerative colitis, under non-invasive 
treatment in the Department of Gastroenterology and in 
the Gastrology Clinic of the Regional Specialised Hospital in 
Czestochowa, Poland. Women constituted 52% of the sample 
group, men – 48%. The patients’ age range was between 18–79, 
mean – 41.02 years. 85% of the patients had secondary and 
higher education, 73% were professionally active. Patients 
living in the city dominated in the sample group. The 
ulcerative colitis duration fluctuated between 1–27 years.
The data were collected by means of the following tools: 
Clinical Disease Activity Index [6], Rating Form of IBD 
Patients Concerns (RFIPC) [7, 8, 9], and the authors’ 
questionnaire.
The disease activity was evaluated by means of the Clinical 
Activity Index, described by Rachmilewitz, which contains 
4 basic questions concerning the disease symptoms and 
4 additional questions about parenteral symptoms. The 
maximum number of points in the questionnaire is 23, the 
minimal – 0. The Rachmilewitz Activity Index of 4 or less 
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points indicates remission of the disease. The Rachmilewitz 
score (RWS), otherwise known as the endoscopic index (EI), 
reflects the endoscopic picture. Also very popular in clinical 
everyday pratice is the Mayo score. The Rachmilewitz score 
has been chosen because this EI has been used in clinical 
practice and data collected from the patients’ medical 
documentation.
The patients’ fears and anxiety, stemming from the course 
of disease and treatment of inflammatory bowel diseases were 
evaluated with the Rating Form of IBD Patients Concerns 
(RFIPC) questionnaire, which takes into account symptoms 
often unnoticed by the clinicians, but are extremely important 
not only for the patient but also for the patient’s family. The 
questionnaire includes 25 questions referring to the level of 
fears in the following areas: impact of the disease on family 
life, intimate life, complications, and own body image with 
relation to stigmatisation. The system of responses is based 
on the Visual Analogue Scale (VAS), measuring 100 mm, 
where 0 means no symptoms and 100 the greatest intensity. 
The RFIPC questionnaire result below the mean of 38.7 
indicates less fears and better quality of life.
The data was analysed with descriptive statistics and 
parametric and non-parametric tests depending on the 
type of scale and the character of distribution of variables. 
Correlation analyses for the variables expressed on ordinal 
scales were performed by Pearson’s r correlation coefficient. 
The results were considered statistically significant at p<0.05. 
The research was permitted by the Regional Medical Chamber 
in Czestochowa (Nr. K.B.Cz.-9/2012).
RESULTS
Data analysis showed that the vast majority of patients (64%) 
obtained a result between 5–17 points on the Rachmilewitz 
scale which indicated the disease activity. The mean disease 
activity index in remission was observed at the level of 2.19, 
and in the active phase at 6.45. Men displayed a slightly higher 
disease activity (mean – 5.0; dispersion – 0–17), than women 
(mean – 4.8; dispersion – 0–12).
Figure 1. Mean values of disease remission and activity
Data analysis showed that 73% of patients showed a result 
above 38.7 mm (mean – 65.3 mm), which indicated a lower 
level of quality of life due to disease-related fears anxieties. A 
higher quality of life was found in 27% of patients, and more 
than a half (52%) of this group were women.
The influence of the disease on the level of fears and 
anxieties was significant – 80% of patients showed a mean 
result of 63.7 mm, indicating negative disease effect on the 
quality of life.
In the sphere of intimate life, the mean result was 49.1 mm 
which was presented by 60% of the researched patients.
Analysis of complications accompanying ulcerative colitis 
showed a very high level, with the mean result of 60.7 mm 
in 85% of patients, which indicated a high level of fears and 
anxiety.
Figure 2. Level of fears and anxiety in the sample group
The sphere of stigmatisation showed a mean value of fears 
and anxieties at the level of 53.1, which was displayed by 60% 
of the patients.
The highest level of fears and anxieties was observed in 
the spheres concerning complications and disease impact on 
the patients’ lives. An only slightly lower value was observed 
with reference to stigmatisation. A lower level of fears and 
anxieties accompanied the intimate life of the researched 
patients.
In the sample group, an almost complete correlation 
was found between the general level of fears and anxieties 
RFIPC  and the disease impact (r=0.98; p<0.001), and the 
level of fears and anxiety RFIPC and intimate life (r=0.91; 
p<0.001).
A very high correlation was observed between the level 
of fears and anxieties RFIPC and stigmatisation (r=0.90; 
p<0.001) and the level of fears and anxieties RFIPC and 
complications (r=0.84; p<0.001).
The presented results may indicate that the higher the 
level of fears and anxieties, the higher the levels of particular 
spheres: disease impact on life, fears related to intimate 
life, stigmatisation and complications. The researched 
women displayed a higher level of fears (mean – 57.8 mm) 
compared to men (mean – 52.4 mm), but this difference was 
not statistically significant.
Table 1. Descriptive statistics of particular REIPC spheres
Descriptive statistics
No. of patients Mean Minimum Maximum SD
Disease impact 102 55,11 1,57 99,30 21,73
Intimate life 102 49,10 0,5 100,00 32,06
Complications 102 60,73 3 99,60 23,48
Stigmatisation 102 53,12 0 100,00 30,62
SD – standard deviation
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In order to compare the levels of fears and anxieties with 
reference to age, the division into 2 age groups was made: 
under 50 years of age and over 50 years. A lower level of fears 
and anxieties was observed in older patients, with a mean 
level of 47.50 mm, and in patients under 50 the mean level was 
57.80 mm. The differences were not statistically significant.
A higher level of fears and anxieties was observed in 
patients with a longer course of disease. Patients with a 
lower levels of fears and anxieties showed a medium course 
of disease – 4.8 years, patients with higher level of fears and 
anxieties – 7.92 years.
Analysis of the relationship between the activity and 
remission of ulcerative colitis showed that the patients in 
remission displayed a lower level of fears and anxieties (mean 
– 52.40  mm), compared to the group in the active phase 
(mean – 56.70 mm).
DISCUSSION
The presented study analyses the level of fears and anxiety, 
as well as the disease activity in a group of patients with 
ulcerative colitis. The active phase was observed in 64% 
of patients, which indicates a chronic process. Numerous 
authors indicate the chronic character of ulcerative colitis 
[10, 11, 12].
The clinical condition of the patient influences their 
physical and mental functioning, and on the quality of life 
related to health. J. Andrzejewska and D. Talarska draw 
attention to the fears and anxieties present in patients with 
ulcerative colitis, often unnoticed by the therapeutic team, 
and even the patients themselves [7]. The presence of fears 
and anxieties in these patients is also confirmed by J. E. 
Mawdsley and D. S. Ramptom [13], according to whom fears 
and anxieties are the dominant emotions accompanying 
chronic diseases, and may lead to problems with the reception 
and processing of information, misinterpretation of facts, 
as well as impairment of cognitive functions, i.e. memory 
and concentration [13]. Numerous authors [14, 15, 16] have 
confirmed that anxiety is common in patients with ulcerative 
colitis and stems from, among others, fear of deterioration in 
health, the feeling of pain, numerous diagnostic examinations 
and medical appointments, and the necessity of frequent 
hospitalisation [17, 18].
Ulcerative colitis impacts on every sphere of the patient’s life 
and lowers its quality. This aspect has been frequently referred 
to by authors researching the evaluation of biopsychosocial 
functioning of this group of patients [7, 10, 19, 20, 21, 22, 
23, 24, 26].
The author’s own research showed that the mean level 
of fears and anxiety in the sample group amounted to 
46.2 mm, and the highest level was observed in the sphere 
of complications – 6.7, and the disease impact on the 
patients’ life – 55.1  mm. The above results differ slightly 
from those described by D. A. Drossman et al. [8] and by 
J. Andrzejewska et al. [27]. However, similar results for the 
levels of fear and anxiety were obtained with reference to 
gender. Women displayed a higher level of fears and anxiety 
than men [8, 28].
CONCLUSIONS
1) The patients presented high levels of fear and anxiety which 
determined the low quality of their lives.
2) There is a correlation between the disease activity, gender, 
age and duration of disease, and the level of fear and 
anxiety.
3) A relationship was observed between the general level 
of fear and anxiety and the patients’ spheres of life, i.e. 
the disease impact, intimate life, complications and 
stigmatisation.
Limitation of the study. The main limitation of this study is 
that the examined patients represented a very wide range of 
age (18–79 years) which could potentially cause bias. Further 
research should therefore be undertaken.
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